Financial Performance - The company incurred a net loss of $2,029,682 for the six months ended December 31, 2024, and a cumulative net loss of $39.9 million since its incorporation on November 14, 2017[91][96]. - Revenue for the six months ended December 31, 2024, was approximately $24,000, a significant decrease from $105,000 for the same period in 2023[114]. - Interest income for the six months ended December 31, 2024, was approximately $28,500, compared to $110,000 for the same period in 2023[124]. - One customer accounted for approximately 94% of total revenue for the six months ended December 31, 2024[112]. Cash and Financing - As of December 31, 2024, the company's cash and cash equivalents totaled $519,706, down from $2,071,016 as of June 30, 2024[107]. - The company has raised approximately $11,760,000 from private placement financing transactions since its inception, with a public offering on January 8, 2025, generating approximately $3.08 million in cash proceeds[97][100]. Expenses - General and administrative expenses increased to approximately $1,438,000 for the six months ended December 31, 2024, compared to approximately $882,000 for the same period in 2023[119]. - Technology and content development expenses decreased to approximately $352,000 for the six months ended December 31, 2024, from approximately $664,000 in the same period in 2023[121]. - Sales and marketing expenses were approximately $293,000 for the six months ended December 31, 2024, down from approximately $464,000 for the same period in 2023[123]. - Capital asset additions for the six months ended December 31, 2024, were $212,600, compared to $118,000 in the same period of 2023, indicating a significant increase in capital expenditures[126]. Compliance and Regulatory Issues - The Company received a Nasdaq deficiency letter on November 26, 2024, due to non-compliance with the Stockholders' Equity Requirement of $2,500,000[127]. - The Company submitted a plan to regain compliance on January 10, 2025, and believes it has regained compliance following a public offering[128]. - Nasdaq confirmed compliance with the Stockholders' Equity Requirement on January 23, 2025, but warned of potential delisting if compliance is not evidenced in the next periodic report[128]. Internal Controls - Management concluded that disclosure controls and procedures were not effective due to identified material weaknesses in internal control over financial reporting[132]. - Specific material weaknesses included deficiencies in reviewing and approving journal entries and ensuring accurate stock compensation expense calculations[134]. - The Company is taking steps to remediate material weaknesses, including documenting processes and controls for business transactions[138]. - There were no changes in internal control over financial reporting that materially affected the Company's controls during the period ended December 31, 2024[137]. - The Company plans to formalize processes for monitoring internal control over financial reporting to improve overall effectiveness[138]. - There is no assurance that current or planned remediation measures will be sufficient to address identified material weaknesses[136]. Going Concern - The company has substantial doubt about its ability to continue as a going concern due to ongoing net losses and negative cash flows[92][105].

Company Overview - Amesite, Inc. is a pioneering technology company specializing in B2C and B2B AI-driven solutions, with a focus on developing applications that enhance efficiency and reduce costs in various sectors [3] - The company has launched NurseMagic™, an AI-powered application designed specifically for nursing professionals and home health care workers, which streamlines documentation and enhances patient communication [3] Product Details - NurseMagic™ has seen rapid adoption, with users across all fifty U.S. states and twenty-one countries, indicating strong market penetration [2] - The application offers a suite of tools for nursing professionals, including the ability to create nursing notes in multiple formats such as SOAP, SOAPIER, Narrative, and ISBAR within seconds [2] - Testimonials from paying customers validate the product's market fit and its effectiveness as a gamechanger in the healthcare sector [2] Market Context - The healthcare sector targeted by NurseMagic™ is valued at approximately $130 billion, presenting significant growth opportunities for the company [2] - The company aims to deliver value to both business owners and employees within this sector through its innovative solutions [2]

Core Insights - Amesite, Inc. is participating in The Microcap Conference 2025, focusing on growth opportunities for companies and investors [1] - The CEO, Dr. Ann Marie Sastry, will present updates on the NurseMagic™ app and discuss growth strategies [2] - NurseMagic™ is an AI-powered mobile application aimed at enhancing the efficiency of nursing professionals and home health care workers [3][4] Company Overview - Amesite, Inc. specializes in B2C and B2B AI-driven solutions, leveraging proprietary AI infrastructure [4] - The NurseMagic™ app streamlines nursing documentation, improves patient communication, and provides personalized guidance for nurses [4]

Core Viewpoint - Amesite Inc. has successfully closed a public offering of 1,201,667 shares at a price of $3.00 per share, raising approximately $3.6 million, with participation from certain officers and directors totaling around $1.26 million [1][2]. Group 1: Offering Details - The public offering was underwritten on a "best efforts" basis, with Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC serving as joint book-running managers [2]. - The net proceeds from the offering will be allocated for general corporate purposes, capital expenditures, working capital, and general and administrative expenses [2]. Group 2: Company Overview - Amesite Inc. specializes in developing and marketing AI-driven solutions for both B2C and B2B markets, leveraging proprietary AI infrastructure [5]. - The company offers applications such as NurseMagic™, a mobile app designed for health and care professionals, which aids in nursing documentation, enhances patient communication, and provides personalized guidance [5]. Group 3: Regulatory Information - A shelf registration statement related to the public offering was filed with the SEC and declared effective on December 18, 2024 [3]. - A preliminary prospectus supplement and accompanying prospectus for the offering are available on the SEC's website [3].

Core Viewpoint - Amesite Inc. has announced a public offering of 1,201,667 shares at a price of $3.00 per share, aiming to raise approximately $3.6 million, with participation from certain officers and directors for about $1.26 million [1][2]. Group 1: Offering Details - The public offering is underwritten on a "best efforts" basis and is expected to close on January 8, 2025, pending customary closing conditions [1]. - Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC are serving as joint book-running managers for the offering [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for general corporate purposes, capital expenditures, working capital, and general and administrative expenses [2]. Group 3: Company Overview - Amesite Inc. specializes in AI-driven solutions for both B2C and B2B markets, leveraging proprietary AI infrastructure to develop applications that meet individual and professional needs [5]. - The company's mobile app, NurseMagic™, assists health and care professionals by streamlining nursing documentation, enhancing patient communication, and providing personalized guidance [5].

Core Viewpoint - Amesite Inc. intends to conduct a public offering of its common stock or pre-funded warrants, subject to market conditions, with no assurance on the timing or terms of the offering [1]. Group 1: Offering Details - The offering will be managed by Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC as joint book-running managers [2]. - The net proceeds from the offering will be utilized for general corporate purposes, capital expenditures, working capital, and general and administrative expenses [2]. - A shelf registration statement related to the public offering was filed with the SEC and declared effective on December 18, 2024 [3]. Group 2: Company Overview - Amesite Inc. specializes in developing and marketing AI-driven solutions for both B2C and B2B markets [5]. - The company offers applications that cater to individual and professional needs, including NurseMagic™, a mobile app designed for health and care professionals to streamline nursing documentation and enhance patient communication [5].

Core Insights - Amesite Inc. is set to present its growth strategy for NurseMagic, targeting both B2C and B2B users across 50 states and 21 countries, covering 87 professions [1][3][4] - The presentation will take place at the Sidoti January Virtual Investor Conference on January 22-23, 2025, with live access available through Amesite's website [2] Company Overview - Amesite Inc. specializes in AI-driven solutions for B2C and B2B markets, including a mobile app called NurseMagic that enhances healthcare professionals' efficiency [5] - NurseMagic supports a wide range of healthcare professionals, including registered nurses, physicians, EMTs, and healthcare executives, demonstrating significant user growth since its launch [3][5] Sales and Market Potential - The company has reported strong enterprise sales, particularly among franchisees of major home care providers, indicating a robust market response to NurseMagic [4] - Amesite's CEO highlighted the potential for sustainable revenue growth due to the efficiency improvements NurseMagic offers in healthcare settings [4]

Presentation Includes Discussion of Monetization of NurseMagic™ DETROIT, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced today it will release an end of year video shareholder update to its website today, December 23, 2024 at 3:00 pm ET. The presentation will be available to shareholders here: https://ir.amesite.com/news-events/media. As part of the update, Amesite's CEO ...

Company Dramatically Increasing Its Reach and Engagement as It Scales B2C and B2B Sales with AI-First Solution in HealthcareDETROIT, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), creator of the AI-powered NurseMagic™ app, announces significant marketing growth alongside its enterprise and consumer sales success. NurseMagic™ harnesses advanced AI to provide intelligent, real-time support for caregivers, transforming how care is delivered and managed. By building B2B and B2C visibility in par ...

DETROIT, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), creator of the NurseMagic™ app, has closed on contracts with franchise owners representing nationally recognized brands that operate hundreds of locations across the country. These initial contract wins represent a major milestone for NurseMagic™, proving its value as a repeatable, scalable solution for franchise businesses. By addressing critical challenges in workforce performance and engagement, NurseMagic™ delivers immediate ROI with ...